Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 27;15:3285–3301. doi: 10.2147/DMSO.S380053

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Tong et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Hepatic FST level was elevated in NAFLD liver samples compared to normal liver samples. (A) H&E staining of liver sections in NAFLD and normal liver samples (200×, scale bar: 100 µm). (B and C) Immunohistochemical staining and analysis result of hepatic FST in NAFLD and normal liver samples (400×, scale bar: 50 µm). (D) Immunofluorescence staining of hepatic FST in NAFLD and normal liver samples. (630×, scale bar: 20 µm). (E and F) The protein level and analysis result of hepatic FST in NAFLD and normal liver samples. β-actin was used as a loading control.

Note: n= 6. *P< 0.05 vs normal group.

Abbreviations: FST, follistatin; NAFLD, non-alcoholic fatty liver disease; H&E, hematoxylin and eosin.